Real-time enrollment status for this lymphohistiocytosis, hemophagocytic clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:16 PM UTC
| NCT Number | NCT06339177 |
| Recruiting Status | Recruiting |
| Condition | Lymphohistiocytosis, Hemophagocytic |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 2 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | March 20, 2026 (Mar 20, 2026) |
As of July 13, 2026: Clinical trial NCT06339177 is currently recruiting participants. This clinical trial study for lymphohistiocytosis, hemophagocytic is actively seeking new participants at 2 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06339177 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06339177 was last updated Mar 20, 2026 (March 20, 2026). HelloStudys verifies this status automatically.